APRE: Aprea Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 8.51
Enterprise Value ($M) -13.03
Book Value ($M) 20.62
Book Value / Share 3.75
Price / Book 0.41
NCAV ($M) 20.22
NCAV / Share 3.68
Price / NCAV 0.42

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.39
Return on Equity (ROE) -0.43

Liquidity (mrq)
Quick Ratio 7.01
Current Ratio 7.01

Balance Sheet (mrq) ($M)
Current Assets 23.58
Assets 23.98
Liabilities 3.36
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1.50
Operating Income -14.32
Net Income -12.96
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -13.56
Cash from Investing -0.02
Cash from Financing 14.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
8 days ago 13G/A Sio Capital Management, LLC 5.04 -1.21
02-13 13G/A Stonepine Capital Management, LLC 5.10 -21.63
11-14 13G Nantahala Capital Management, LLC 7.30

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-25 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-15 1,294 11,950 10.83
2025-04-14 2,170 8,023 27.05
2025-04-11 2,321 6,635 34.98
2025-04-10 1,245 16,317 7.63

(click for more detail)

Similar Companies
ANEB – Anebulo Pharmaceuticals, Inc. ANIX – Anixa Biosciences, Inc.
APM – Aptorum Group Limited APVO – Aptevo Therapeutics Inc.
ARTL – Artelo Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io